PSNC shares Brexit position with Health and Social Care Committee

PSNC shares Brexit position with Health and Social Care Committee

December 11, 2018

The Parliamentary Health and Social Care Committee has today published correspondence received from PSNC Chief Executive Simon Dukes about the supply of medicines after Brexit.

Following a meeting last week with Dr Sarah Wollaston, MP for Totnes and Chair of the Health and Social Care Committee, PSNC set out its position on Brexit and medicines supply in a letter.

The letter highlights PSNC’s ongoing work with the Department of Health and Social Care (DHSC) to minimise the impact of Brexit on the medicines supply chain, and also our work with other pharmacy organisations and stakeholders from across the medicines supply chain via the Brexit Forum.

The letter describes a number of potential measures that could be in put in place to help minimise the impact of Brexit on medicines supply, pharmacies and patients, including:

  • allowing pharmacies to generically substitute certain medicines;
  • relaxing the NHS Terms of Service obligation on pharmacists to help pharmacies to better manage medicine supplies;
  • using the new Information Disclosure Regulations to monitor and communicate stock availability pharmacies so that timely interventions can be made to minimise delays in procurement;
  • making Drug Tariff concession pricing more responsive to market prices; and
  • relaxing the restrictions on pharmacy-to-pharmacy wholesale dealing without wholesaler dealers licenses to allow pharmacies to trade stock between them at a local level, helping to allow medicines to reach those patients who most need them without regulatory barriers.

PSNC is pleased that DHSC is now consulting on legislative changes which, in the event of a no-deal Brexit, would assist with implementing many of the measures that we have suggested. We will continue to work closely with them on the detail of that and we have committed to assisting their work in the event of there being a significant impact on the medicines supply chain after Brexit.

Read PSNC’s letter to Dr Sarah Wollaston

Read more information about the ongoing Brexit contingency planning work

Posted in:

More Latest News >

PNA guidance for LPCs published

PSNC and the Department of Health and Social Care (DHSC) have both published guidance on pharmaceutical needs assessments (PNAs). The...